Endosense begins enrollment in EFFICAS study series
12-May-2010 -
Endosense has announced it has enrolled the first patients in EFFICAS I, the first study of the EFFICAS series. These patients were enrolled in Na Homolce Hospital, Prague, Czech Republic and treated by Petr Neuzil, M.D. and Vivek Reddy, M.D. EFFICAS is a study series intended to demonstrate that ...
cardiac arrhythmias
Czech Republic
force sensors
+1